Recent Developments in the Patho-Physiological Molecular Clocks Lab

Thanks to the Warwick Innovation Fund and as part of the Warwick Cancer Research Centre, we will be able to characterise the impact of circadian disruption in breast cancer.

In collaboration with our clinical colleagues, we will investigate the status of the circadian clock in breast cancer tumours and then test what functional consequences can be observed with a disrupted cellular clock. Our goal will be to establish biomarkers for clock disruption on the cellular level and allow to stratify patient populations for, ultimately, tailoring treatments to individual breast cancer patients.

Thank you to all who donated for helping us to start this project!

Scientists from the University of Warwick, and around the world, talk about their weird and wonderful research in trying to uncover life's inner workings.

Chronotherapy: treating cancer at the right time, The Pharmaceutical Journal, Vol 296, No 7886

DOI: 10.1211/PJ.2016.20200709.

Happy to welcome Laura, Lauren and Ewan to Warwick and to the world of circadian clocks.

Panel discussion about Chronotherapy in the clinic at the University of Warwick.